Lotemax

Active Ingredient(s): Loteprednol
FDA Approved: * March 9, 1998
Pharm Company: * BAUSCH AND LOMB
Category: Anti-Inflammatory

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. It was patented in 1980 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Furt... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Lotemax 5 mg/ml Ophthalmic Suspension/ Drops

NDC: 24208-299

Labeler:

Bausch & Lomb Incorporated

Lotemax 5 mg/g Ophthalmic Ointment

NDC: 24208-443

Labeler:

Bausch & Lomb Incorporated

Lotemax 5 mg/g Ophthalmic Gel

NDC: 24208-503

Labeler:

Bausch & Lomb Incorporated

Lotemax 5 mg/ml Ophthalmic Suspension/ Drops

NDC: 54868-4278

Labeler:

Physicians Total Care, Inc.

Related Brands

Drugs with the same active ingredients